ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone Side Effect Management
Study: The Effect of HCG on BPH
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Nelson Vergel" data-source="post: 48481" data-attributes="member: 3"><p><strong>A trial study: the effect of low dose human chorionic gonadotropin on the symptoms of benign prostatic hyperplasia.</strong></p><p></p><p>Randomized controlled trial</p><p></p><p>Godschalk MF, et al. J Urol. 2003.</p><p></p><p>Authors</p><p></p><p>Godschalk MF1, Unice KA, Bergner D, Katz PG, Mulligan T, McMichael J.</p><p></p><p></p><p>1Virginia Commonwealth University School of Medicine, Richmond, USA. </p><p></p><p>J Urol. 2003 Oct;170(4 Pt 1):1264-9.</p><p></p><p>Abstract</p><p></p><p>PURPOSE: Human chorionic gonadotropin (HCG) is a glycoprotein hormone with multiple physiological functions. It interferes with mammary tumorigenesis and modulates growth and tumorigenesis in prostate cancer cells. In addition, HCG receptor transcripts and protein have been demonstrated in normal and hyperplastic prostate glands. Functionally HCG has a growth modulating effect on androgen independent prostate cell lines. We investigated the possible clinical effects of HCG on the symptoms associated with benign prostatic hyperplasia (BPH) in this trial study.</p><p></p><p>MATERIALS AND METHODS: We performed a multicenter, double-blind, placebo controlled, randomized pilot study evaluating the effects of low dose HCG vs placebo in 101 men (50 to 79 years old) with BPH. The primary efficacy measure was the American Urological Association total symptom index score. Secondary efficacy parameters included peak urinary flow and sexual self-efficacy questionnaire changes.</p><p></p><p>RESULTS: Low dose HCG appeared to positively effect moderate to severe BPH symptoms according to American Urological Association scores and sexual function but not peak urinary flow. No HCG induced changes were noted in prostate specific antigen or prostate volume.</p><p></p><p>CONCLUSIONS: These findings suggest that HCG may provide a well tolerated and beneficial therapy for BPH that will be investigated in subsequent studies.</p></blockquote><p></p>
[QUOTE="Nelson Vergel, post: 48481, member: 3"] [B]A trial study: the effect of low dose human chorionic gonadotropin on the symptoms of benign prostatic hyperplasia.[/B] Randomized controlled trial Godschalk MF, et al. J Urol. 2003. Authors Godschalk MF1, Unice KA, Bergner D, Katz PG, Mulligan T, McMichael J. 1Virginia Commonwealth University School of Medicine, Richmond, USA. J Urol. 2003 Oct;170(4 Pt 1):1264-9. Abstract PURPOSE: Human chorionic gonadotropin (HCG) is a glycoprotein hormone with multiple physiological functions. It interferes with mammary tumorigenesis and modulates growth and tumorigenesis in prostate cancer cells. In addition, HCG receptor transcripts and protein have been demonstrated in normal and hyperplastic prostate glands. Functionally HCG has a growth modulating effect on androgen independent prostate cell lines. We investigated the possible clinical effects of HCG on the symptoms associated with benign prostatic hyperplasia (BPH) in this trial study. MATERIALS AND METHODS: We performed a multicenter, double-blind, placebo controlled, randomized pilot study evaluating the effects of low dose HCG vs placebo in 101 men (50 to 79 years old) with BPH. The primary efficacy measure was the American Urological Association total symptom index score. Secondary efficacy parameters included peak urinary flow and sexual self-efficacy questionnaire changes. RESULTS: Low dose HCG appeared to positively effect moderate to severe BPH symptoms according to American Urological Association scores and sexual function but not peak urinary flow. No HCG induced changes were noted in prostate specific antigen or prostate volume. CONCLUSIONS: These findings suggest that HCG may provide a well tolerated and beneficial therapy for BPH that will be investigated in subsequent studies. [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone Side Effect Management
Study: The Effect of HCG on BPH
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top